Clinical Observation of Intradermal Injections With Botulinum Toxin A in the Treatment of Rosacea Erythema Telangiectasia
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
the goal of this study is to study the clinical efficacy and safety of botox in the treatment of rosacea.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 60
Healthy Volunteers: t
View:
• Meeting the diagnostic criteria of mild to moderate erythema telangiectasis rosette acne;
• more than 18 years old;
• to obey the rules of the treatment in the study, and can be followed up for 12 weeks;
• informed consent;
Locations
Other Locations
China
Jie Dai
RECRUITING
Nanjing
Contact Information
Primary
Jie Dai
karry_dj@126.com
02552271117
Time Frame
Start Date: 2022-04-01
Estimated Completion Date: 2024-06-28
Participants
Target number of participants: 30
Treatments
Experimental: left cheek and right cheek
First, apply an appropriate amount of lidocaine cream to your face and wait (30-45 minutes) for the anesthetic to take effect;~Second step, after cleaning, mark the injection site on your face, about 25-30 points on one cheek, 1 cm apart, using a randomized half face control trial, Use of botulinum toxin type A for injection (Botox) (Allergan Pharmaceticals Ireland Limited, Import Drug Registration No. : S20171003), 0.5U botulinum toxin type A (Botox) was injected per point on one cheek and 1U on the other. The total amount of botulinum toxin type A was between 15 and 30U on each side.
Related Therapeutic Areas
Sponsors
Leads: Nanjing First Hospital, Nanjing Medical University